Clinical Trial Update: Early Methylene Blue in the Microhemodynamics of Septic Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating methylene blue for septic shock and hypoperfusion is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoperfusion
• Septic Shock

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva | Conditions: Septic Shock, Hypoperfusion | Phase 2, Phase 3 | Status: RECRUITING